Progress in diagnosis and treatment of mucinous breast cancer
Mucinous breast carcinoma(MBC)is a rare and special type of breast cancer,which mainly occurs in postmenopausal women.It is usually found during mammography screening,but some patients may show palpable masses.MBC is a tumor with good histological differentiation,which is characterized by a large amount of extracellular mucus around tumor cells.According to the amount of mucin,MBC can be divided into pure mucinous breast carcinoma(PMBC)or mixed mucinous breast carcinoma(MMC).Compared with non-specific invasive ductal carcinoma(IDC-NST),the MBC genome is more stable and has a relatively better prognosis.However,because of the low incidence rate,the study of MBC is characterized by a small sample or short-term follow-up,and the relevant guidelines have no clear recommendations on its treatment.Due to limited evidence-based medicine evidence of evidence-based medicine related to MBC treatment.This article provides a review of the clinical pathology,genomics,prognostic characteristics,and treatment progress of MBC.
Mucinous breast cancerPathological characteristicsPrognosisGenomicsTreatment progress
NETL
NSTL
万方数据
